ArticleZhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery2026
[Interpretation of 2024 United Kingdom National Osteoporosis Guideline Group (NOGG) Clinical Guidelines: Prevention and Treatment of Osteoporosis].
Article in Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- First Contact Physiotherapists (FCPs) Referral Practices to Rheumatology: A Scoping Review of the Evidence Base.Musculoskeletal care · 2026Article
- First contact physiotherapists: are they able to reduce the burden on rheumatology services? A critical review of the evidence base.Rheumatology advances in practice · 2024Review
- Call to action: a five nations consensus on the use of intravenous zoledronate after hip fracture.Age and ageing · 2023Article
- Article
- Nanoscale mechanisms in age-related hip-fractures.Scientific reports · 2020Article
- Persistence and compliance with osteoporosis therapies among postmenopausal women in the UK Clinical Practice Research Datalink.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the accelerating aging of the global population, osteoporosis and its associated complications have posed significant challenges to public health systems worldwide. The United Kingdom National Osteoporosis Guideline Group (NOGG) recently released the 2024 edition of its clinical guideline for the prevention and treatment of osteoporosis, underpinned by the most recent evidence-based medical data. This guideline provides comprehensive guidance on screening and assessment, pharmacological intervention strategies, and the promotion of bone health. This article offers an in-depth interpretation of the updated guideline and compares the similarities and differences between Chinese and 2024 NOGG guidelines regarding intervention thresholds, pharmacological sequencing, and efficacy monitoring. By analyzing the advanced management strategies introduced in the 2024 NOGG guideline, this paper explores its application value within the Chinese clinical context, aiming to optimize local prevention and treatment protocols and enhance the quality of long-term disease management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.